NYSE:ICD - New York Stock Exchange, Inc. - US4534156066 - Common Stock - Currency: USD
0.5858
-0.06 (-9.88%)
The current stock price of ICD is 0.5858 USD. In the past month the price decreased by -58.75%. In the past year, price decreased by -81.4%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
NE | NOBLE CORP PLC | 11.69 | 4.33B | ||
PTEN | PATTERSON-UTI ENERGY INC | 207.58 | 3.21B | ||
VAL | VALARIS LTD | 7.97 | 2.92B | ||
RIG | TRANSOCEAN LTD | N/A | 2.90B | ||
HP | HELMERICH & PAYNE | 8.38 | 2.69B | ||
SDRL | SEADRILL LIMITED | 9.86 | 2.00B | ||
BORR | BORR DRILLING LTD | 8.98 | 759.23M | ||
PDS | PRECISION DRILLING CORP | 10.36 | 740.81M | ||
NBR | NABORS INDUSTRIES LTD | N/A | 473.38M |
Independence Contract Drilling, Inc. engages in the provision of land-based contract drilling services for oil and natural gas producers. The company is headquartered in Houston, Texas and currently employs 450 full-time employees. The company went IPO on 2014-04-21. The firm constructs, owns and operates a fleet of pad-optimal ShaleDriller rigs that are specifically engineered and designed to improve its clients production profiles. The firm's operations are focused on unconventional resource plays located in geographic regions that it can support from its Houston, Texas and Midland, Texas facilities. The firm's rig fleet includes approximately 26 pad-optimal, superspec AC powered (AC) rigs. Its rigs are operating in the Permian Basin and the Haynesville Shale. The firm's customers for contract drilling services in the United States include oil and natural gas companies, independent oil and natural gas companies, as well as small to mid-sized publicly-traded and privately held oil and natural gas companies.
INDEPENDENCE CONTRACT DRILLI
20475 State Highway 249, Suite 300
Houston TEXAS 77070 US
CEO: J. Anthony Gallegos
Employees: 450
Company Website: https://www.icdrilling.com/
Phone: 12815981230
The current stock price of ICD is 0.5858 USD. The price decreased by -9.88% in the last trading session.
The exchange symbol of INDEPENDENCE CONTRACT DRILLI is ICD and it is listed on the New York Stock Exchange, Inc. exchange.
ICD stock is listed on the New York Stock Exchange, Inc. exchange.
5 analysts have analysed ICD and the average price target is 3.57 USD. This implies a price increase of 509.42% is expected in the next year compared to the current price of 0.5858. Check the INDEPENDENCE CONTRACT DRILLI stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INDEPENDENCE CONTRACT DRILLI (ICD) has a market capitalization of 8.92M USD. This makes ICD a Nano Cap stock.
INDEPENDENCE CONTRACT DRILLI (ICD) currently has 450 employees.
INDEPENDENCE CONTRACT DRILLI (ICD) has a resistance level at 1.42. Check the full technical report for a detailed analysis of ICD support and resistance levels.
The Revenue of INDEPENDENCE CONTRACT DRILLI (ICD) is expected to decline by -20.87% in the next year. Check the estimates tab for more information on the ICD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ICD does not pay a dividend.
INDEPENDENCE CONTRACT DRILLI (ICD) will report earnings on 2024-10-30, after the market close.
INDEPENDENCE CONTRACT DRILLI (ICD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.21).
ChartMill assigns a fundamental rating of 1 / 10 to ICD. Both the profitability and financial health of ICD have multiple concerns.
Over the last trailing twelve months ICD reported a non-GAAP Earnings per Share(EPS) of -2.21. The EPS decreased by -662.07% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -15.8% | ||
ROE | -37.58% | ||
Debt/Equity | 1.08 |
ChartMill assigns a Buy % Consensus number of 80% to ICD. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of -146.84% and a revenue growth -20.87% for ICD